Fulton Breakefield Broenniman LLC Has $1.84 Million Stock Holdings in Procter & Gamble Company (The) $PG

Fulton Breakefield Broenniman LLC raised its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 19.2% in the 2nd quarter, HoldingsChannel reports. The firm owned 11,569 shares of the company’s stock after buying an additional 1,867 shares during the period. Fulton Breakefield Broenniman LLC’s holdings in Procter & Gamble were worth $1,843,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after buying an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after buying an additional 1,018,865 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity

In other news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer directly owned 61,764 shares in the company, valued at $9,402,333.72. The trade was a 4.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on PG. Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas restated an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. BNP Paribas Exane decreased their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Wells Fargo & Company decreased their price target on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Finally, Barclays decreased their price target on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 1st. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $172.58.

Procter & Gamble Stock Performance

Procter & Gamble stock opened at $150.67 on Thursday. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The business’s 50-day moving average price is $155.26 and its two-hundred day moving average price is $159.72. The stock has a market cap of $352.64 billion, a PE ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last released its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the previous year, the business posted $1.40 earnings per share. The business’s revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.